| Application no. and date | 18205542.6 (espacenet) (Federated) (European Patent Register), 20150203 | | Patent/reg. no. and date | DK/EP 3498734, 20210901 | | Publication date | 20190619 | | Priority no. and date | US 201461935809 P, 20140204 | | EP pub. no. and date |
EP 3498734 20190619 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US,
Merck Sharp & Dohme LLC, 126 East Lincoln Avenue
P.O. Box 2000
Rahway, New Jersey 07065, US | | Applicant ref. no. | P78461DK01 | | Inventor | MARTINI, Jean-Francais Andre, 7420 Circulo Sequoia
Carlsbad, CA 92009, US,
TARAZI, Jamal Christo, 10867 Pesos Place
San Diego, CA 92124, US,
PERINI, Rodolfo Fleury, 707 Captains Way
Philadelphia, PA 19146, US,
MAURO, David J., 351 North Sumneytown Pike
North Wales, PA 19454, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | KOMBINATION AF EN PD-1-ANTAGONIST OG EN VEGFR-INHIBITOR TIL BEHANDLING AF KRÆFT | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
